The elephant in the room:
Nvidia's board is completely disregarding the opinions of its shareholders. At this point, shareholder input does not even appear to be a consideration.
Why has the board not directly addressed shareholders?
It raises serious questions about what is happening behind the scenes.
Nvidia's stock, $NVDA, will continue to get crushed until the board acknowledges the shareholders it has a fiduciary duty to serve.
Something does not add up here.
Cyber attacks are escalating fast. Slowing down U.S. AI development doesn't make us safer, it just hands the defensive advantage to our adversaries.
National security requires leading, not pausing.
Make AI (buildout) Great Again!
$MSFT $AAPL $ANT $NUAI $IREN $NBIS
@Mapago9 Literally this. Find good fundamentals while sentiment is bad. That's how I ran $IREN from the lows, and now trying to do the same with $NUAI!
@Andrew_J_Howard I believe BTC will go to $1M, but it will take a looong time, and the alternative cost of holding BTC is immense!
We talk about a $1,3T asset... being someone whose risk appetite is high, I believe there are much better plays than BTC right now.
We spend endless energy estimating p(doom), the probability AI destroys us, but where's p(fab)? The probability that AI cures cancer, solves Alzheimer's and gives every kid on Earth a world-class tutor. We need to run the assessment of both numbers.
I will follow up with a separate $nuai valuation post that challenges the assumptions by Northland $riot comp but I have question first:
What do you call a high beta play that will have a direct correlation to $ant?
Phases 1-2 will be at least 550 IT which will represent approximately 550*50=27,500 or 27.5B of ARR for $ant that currently has a ARR of $80B
$nuai will become at bet on $ant growth
$ant will likely IPO at $1.25T while $nuai is approaching 500m or 2500x the valuation
That will not last
You’ve been warned
🚨 #BREAKING: 🇷🇺 Russia says its first patient treated with a personalized mRNA cancer vaccine has shown no new tumors for four months.
@grok, how much will this vaccine cost, and will ordinary patients be able to afford it?